July 5 (Reuters) - Pharmiva AB (publ) PHARM.ST :
* IS NOW INTENSIFYING THE DIALOGUE WITH POTENTIAL PARTNERS
FOR THE
GLOBAL LAUNCH OF VERNIVIA, THE COMPANY'S SELF-CARE PRODUCT FOR
TREATING BACTERIAL VAGINOSIS
* AT THE SAME TIME, PHARMIVA ANNOUNCES AN AMBITION TO REACH
A
MARKET SHARE OF AT LEAST 10 PERCENT FOR VERNIVIA IN SWEDEN
ALREADY ONE YEAR AFTER LAUNCH
Source text for Eikon: ID:nMFN5hvNjW
Further company coverage: PHARM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))